Home > Press > Nanoink Launches New Application For Single Cell Arrays At Ascb Annual Meeting
Abstract:
NanoFabrication Systems Division to present groundbreaking poster and exhibit regarding live single cell arrays
NanoInk's NanoFabrication Systems Division is pleased to announce the launch of a new application for single cell studies that enables micropatterning of proteins and polyethylene glycol (PEG) based hydrogel at sub cellular scales. The new application note will be available on NanoInk's Web site in the coming weeks. The NanoFabrication Systems Division will also be presenting a poster and exhibiting at the ASCB (American Society for Cell Biology) 50th Annual Meeting, from Sunday, December 12 through Wednesday, December 15, at the Pennsylvania Convention Center in Philadelphia, Pa.
"The new application demonstrates successful use of the NLP 2000 System to investigate cell response to its microenvironment at single cell levels," said Tom Warwick, general manager, NanoInk's NanoFabrication Systems Division. "We envision that this will enable studies in live single cell arrays, nanotoxicology, developmental biology, tissue engineering, cell physiology, chemotaxis, migration, and mechanotransduction."
Launched in 2009 as a tool for bioscience research, NanoInk's NLP 2000 System is a simple, userfriendly desktop nanolithography platform. The system leverages patented Dip Pen Nanolithography® (DPN®) technology to deposit sub-cellular-scale features of a wide variety of materials with nanoscale registry, all under ambient conditions. With the addition of the new capability to its portfolio of biological research support materials, NanoInk continues to serve as a true partner to the life science community.
NanoInk has successfully demonstrated the patterning of single cells on protein arrays constructed using NanoInk's NLP 2000. Multi-component arrays at sub cellular scales patterned with nanoscale registry have been used to investigate the cellular response at single cell levels. Cell binding areas are constructed using ECM proteins and PEG-based hydrogels are used for targeted delivery of materials to single cells.
ASCB 2010
John M. Collins, Ph.D., NanoInk, will be presenting a poster entitled, "Direct Protein Deposition for Single Cell Analysis" that will show how cells bind to an ECM protein and ‘anchor' it over the top of a PEG hydrogel. It will be presented on Tuesday, December 14, from 11:30 a.m. to 1 p.m. at exhibit halls A/B/C of the Pennsylvania Convention Center. It is program #3144 and board #L381. NanoInk will also be exhibiting at booth #625 where its NLP 2000 System desktop nanolithography platform will be available for demonstrations.
Please visit www.nanoink.net or call (847) 679-8807 for more information on the NanoFabrication Systems Division, the NLP 2000 System, and related Application Notes.
NanoInk, the NanoInk logo, Dip Pen Nanolithography, DPN, NanoEncryption, NanoGuardian, NanoProfessor, NanoStem are trademarks or registered trademarks of NanoInk, Inc.
####
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop.
Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net.
For more information, please click here
Contacts:
Joshua Taustein
Dresner Corporate Services
(312) 780-7219
David Gutierrez
Dresner Corporate Services
(312) 780-7204
Copyright © NanoInk
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||